Zhejiang Huahai Pharmaceutical Co., Ltd. (ZHEJIANG HUAHAI PHARMACEUTICAL ) aksje
600521.SS
ZHEJIANG HUAHAI PHARMACEUTICAL
Market Cap
$22,982,819,840
Om Zhejiang Huahai Pharmaceutical Co., Ltd. (ZHEJIANG HUAHAI PHARMACEUTICAL ) aksje
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. Further, it operates as a pharmaceutical company. Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.
Selskapsinformasjon
317024 Linhai, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.